These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 8068578

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG, Kaan EC, Christen MO, Löw-Kröger A, Mest HJ, Molderings GJ.
    Ann N Y Acad Sci; 1995 Jul 12; 763():659-72. PubMed ID: 7677385
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Historic aspects in the identification of the I1 receptor and the pharmacology of imidazolines.
    Dominiak P.
    Cardiovasc Drugs Ther; 1994 Mar 12; 8 Suppl 1():21-6. PubMed ID: 8068577
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. I1 imidazoline agonists. General clinical pharmacology of imidazoline receptors: implications for the treatment of the elderly.
    Prichard BN, Graham BR.
    Drugs Aging; 2000 Aug 12; 17(2):133-59. PubMed ID: 10984201
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN, Owens CW, Graham BR.
    J Hum Hypertens; 1997 Aug 12; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [Abstract] [Full Text] [Related]

  • 11. Pharmacology of moxonidine, an I1-imidazoline receptor agonist.
    Ziegler D, Haxhiu MA, Kaan EC, Papp JG, Ernsberger P.
    J Cardiovasc Pharmacol; 1996 Aug 12; 27 Suppl 3():S26-37. PubMed ID: 8872297
    [Abstract] [Full Text] [Related]

  • 12. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents.
    Head GA.
    Ann N Y Acad Sci; 1999 Jun 21; 881():279-86. PubMed ID: 10415926
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Direct evidence for imidazoline (I1) receptor modulation of ethanol action on norepinephrine-containing neurons in the rostral ventrolateral medulla in conscious spontaneously hypertensive rats.
    Li G, Abdel-Rahman AA.
    Alcohol Clin Exp Res; 2007 Apr 21; 31(4):684-93. PubMed ID: 17374048
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relationship between imidazoline and alpha2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents.
    Head GA, Chan CK, Burke SL.
    J Auton Nerv Syst; 1998 Oct 15; 72(2-3):163-9. PubMed ID: 9851565
    [Abstract] [Full Text] [Related]

  • 18. Central imidazoline (I1) receptors as targets of centrally acting antihypertensives: moxonidine and rilmenidine.
    van Zwieten PA.
    J Hypertens; 1997 Feb 15; 15(2):117-25. PubMed ID: 9469786
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C, Parini A.
    J Cardiovasc Pharmacol; 1995 Feb 15; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.